Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Women's Health and Genetics/Laboratory Corporation of America, |
RCV005418372 | SCV006086013 | likely benign | not specified | 2025-05-06 | criteria provided, single submitter | clinical testing | |
| Molecular Genetics Laboratory, |
RCV001174168 | SCV001337290 | likely benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
| Labcorp Genetics |
RCV000863448 | SCV001004110 | benign | Charcot-Marie-Tooth Neuropathy X | 2025-01-26 | criteria provided, single submitter | clinical testing | |
| Prevention |
RCV004754585 | SCV005359313 | likely benign | GJB1-related disorder | 2024-04-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
| Natera, |
RCV001174168 | SCV001453015 | likely benign | Charcot-Marie-Tooth disease | 2020-04-11 | no assertion criteria provided | clinical testing |